GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Current Deferred Revenue

Quantum Genomics (Quantum Genomics) Current Deferred Revenue : $0.00 Mil (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Quantum Genomics's current deferred revenue for the quarter that ended in Dec. 2022 was $0.00 Mil.

Quantum Genomics Current Deferred Revenue Historical Data

The historical data trend for Quantum Genomics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Current Deferred Revenue Chart

Quantum Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quantum Genomics Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Quantum Genomics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (Quantum Genomics) Business Description

Traded in Other Exchanges
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (Quantum Genomics) Headlines

From GuruFocus

Quantum Genomics Announces Granting of New Patents Protecting QGC606

By GuruFocusNews GuruFocusNews 03-28-2022